When my joints started aching and my tendons felt perpetually angry, nobody connected it to my hormones — not even me. I'd assumed that kind of wear-and-tear was just 'getting older.' It wasn't until I went looking for answers that I found a whole body of evidence showing estrogen had been quietly holding my connective tissue together all along. That research changed how I thought about HRT entirely.
Learn more about Rose →Estrogen receptors are present in chondrocytes, the cells that maintain articular cartilage, and estrogen actively suppresses the inflammatory cytokines — particularly IL-1β and TNF-α — that degrade cartilage matrix. When estrogen falls at menopause, this protective brake is released, and cartilage breakdown accelerates. Large observational studies have found that women who use HRT have meaningfully lower rates of osteoarthritis progression, particularly in the knee and hip joints.
Tendons are predominantly collagen — and estrogen directly stimulates the fibroblasts that synthesise and organise collagen fibrils within tendon tissue. After menopause, tendon stiffness and collagen cross-linking change in ways that increase susceptibility to micro-tears and slow repair, which is one physiological explanation for why rotator cuff tears, Achilles tendinopathy, and plantar fasciitis become more common in midlife women. Studies using ultrasound elastography have shown that postmenopausal women on HRT have measurably better tendon mechanical properties than those not using it.
Estrogen plays a direct role in skeletal muscle protein synthesis and satellite cell activation — the process by which muscle fibres repair and rebuild after use. The menopause transition is associated with an accelerated phase of sarcopenia that goes beyond what age alone predicts, and this is partly driven by estrogen withdrawal. Clinical trials have shown that HRT attenuates postmenopausal muscle mass loss, with women on estrogen-based therapy retaining significantly more lean mass compared to controls over the same period.
Maintaining muscle mass matters less if the muscle can't generate force efficiently, and estrogen influences neuromuscular function as well as muscle volume. Research has found that postmenopausal women on HRT demonstrate better grip strength, knee extension strength, and functional power output than age-matched women not using it. This has direct implications for fall risk and physical independence in later decades — benefits that extend well beyond how muscles look or feel.
While improved bone mineral density (BMD) contributes to fracture protection, the reduction in hip fracture risk seen with HRT is larger than BMD improvements alone can explain. Researchers believe the additional protection comes from better muscle strength and coordination reducing fall frequency, improved bone quality at the microarchitectural level, and enhanced periosteal bone geometry — all estrogen-dependent processes that standard DEXA scans don't fully capture. This means fracture risk benefit from HRT is likely being underestimated when measured by BMD alone.
Ligaments, like tendons, are collagen-dense structures that respond to estrogen signalling — but they also respond to its absence in a distinct and sometimes dramatic way. Estrogen withdrawal increases ligament laxity, meaning joints become subtly less stable, which raises injury risk particularly in the knee, ankle, and lumbar spine. This is one reason why the incidence of ACL injuries and lower back instability rises in perimenopausal women, and why HRT may offer protective effects for women who are physically active.
Intervertebral discs contain estrogen receptors in their nucleus pulposus and annulus fibrosus cells, and estrogen supports hydration and proteoglycan content within disc tissue — properties that give discs their shock-absorbing capacity. Menopause is associated with accelerated disc dehydration and height loss, contributing to the spinal compression and back pain that many women notice in their late forties and fifties. Emerging evidence from animal models and small human studies suggests HRT may slow this degenerative process, though large trials are still needed.
DEXA scans measure bone mineral density as a proxy for fracture risk, but bone strength depends equally on trabecular architecture — the internal scaffolding of spongy bone — which estrogen actively maintains by regulating osteoblast and osteoclast activity. When estrogen falls, trabecular thinning and perforation accelerates in ways that reduce bone quality without necessarily causing dramatic DEXA score changes. High-resolution peripheral quantitative CT (HR-pQCT) studies have confirmed that HRT preserves trabecular microarchitecture more effectively than BMD scores alone suggest.
The synovial lining of joints contains estrogen receptors, and estrogen exerts anti-inflammatory effects on synovial tissue by suppressing prostaglandin and cytokine production locally. The joint stiffness, swelling, and aching that many women first notice in perimenopause — often dismissed as early arthritis or 'wear and tear' — frequently reflects estrogen-driven synovial inflammation rather than structural joint damage. Women on HRT consistently report less joint stiffness and improved morning mobility, and this aligns with the known anti-inflammatory mechanisms of estrogen in synovial tissue.
Estrogen modulates the inflammatory response to exercise-induced muscle damage, helping to regulate the repair phase so that recovery is efficient rather than excessive or prolonged. After menopause, the absence of this regulatory effect can mean that delayed onset muscle soreness (DOMS) is more severe, recovery takes longer, and the adaptation signal from exercise is blunted — making it harder to benefit from strength training even when effort is consistent. Some researchers now argue that this estrogen-dependent repair mechanism is a key reason why postmenopausal women on HRT respond better to resistance training programmes.
Estrogen stimulates fibroblast activity and collagen synthesis throughout the body's connective tissue matrix, including the deep fascial layers that anchor muscles, tendons, and organs — not just the skin surface. Women lose approximately 30% of skin collagen in the first five years after menopause, and the same degradation process affects the connective tissue framework that supports pelvic floor function, breast ligament integrity, and muscle compartment structure. While collagen loss in skin is often framed as a cosmetic concern, the same underlying biology has functional consequences that HRT can meaningfully slow.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.